ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000235806.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.035471599	Resistant
ENSG00000235806.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.035836497	Sensitive